Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 5/20 | 0.58 |
| ▸ | CA1 | P00915 | 4/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9239144 | 0.93 | BCL2L1 (0.56) | TSHRTP53TRPA1CA2CA1 | |
| SCHEMBL9222754 | 0.87 | ALDH1A1 (0.64) | TSHRTP53TRPA1CA2CA1 | |
| SCHEMBL70162 | 0.81 | TRPA1 (0.86) | TSHRTP53TRPA1CA2CA1 | |
| SCHEMBL70163 | 0.81 | TRPA1 (0.86) | TSHRTP53TRPA1CA2CA1 | |
| SCHEMBL6038454 | 0.81 | ADRA2A (0.56) | TSHRTP53SRD5A2KMT2AALDH1A1 | |
| SCHEMBL9865481 | 0.81 | TSHR (0.67) | TSHRTP53TRPA1CA2CA1 | |
| SCHEMBL31702246 | 0.81 | TRPA1 (0.86) | TSHRTP53TRPA1CA2CA1 | |
| SCHEMBL3364649 | 0.81 | TRPA1 (0.86) | TSHRTP53TRPA1CA2CA1 | |
| Terephthalic Acid SCHEMBL27595349 | 0.80 | TSHR (0.75) | TSHRTP53TRPA1CA2CA1 | |
| Terephthalic Acid SCHEMBL5053781 | 0.80 | TSHR (1.00) | TSHRTP53CA2CA1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0170105-B1 | BENZOIC ACID DERIVATIVES | Shudo, Koichi, Prof. Dr. (JP) | 1990-10-17 | — | — | EP | claimed |
| EP-0170105-A2 | Benzoic acid derivatives | Shudo, Koichi, Prof. Dr. (JP) | 1986-02-05 | — | — | EP | claimed |
| CN-114345825-B | Mask cleaning method, cleaning liquid, cleaning apparatus, and method for manufacturing organic device | 大日本印刷株式会社 | 2023-08-22 | — | — | CN | disclosed |
| CN-115932027-A | Electrochemical reaction intermediate detection and identification method based on mass spectrum | 武汉大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-114345825-A | Mask cleaning method, cleaning liquid, cleaning apparatus, and method for manufacturing organic device | 大日本印刷株式会社 | 2022-04-15 | — | — | CN | disclosed |
| WO-2021136390-A1 | BLOOD COAGULATION FACTOR XIA INHIBITOR | 上海京新生物医药有限公司 | 2021-07-08 | — | — | WO | disclosed |
| US-20210079037-A1 | LIGHT-SWITCHABLE POLYPEPTIDE AND USES THEREOF | Technische Universität München (DE) | 2021-03-18 | — | — | US | disclosed |
| EP-3621983-A1 | LIGHT-SWITCHABLE POLYPEPTIDE AND USES THEREOF | Technische Universität München (DE) | 2020-03-18 | — | — | EP | disclosed |
| CN-110637026-A | Photoconverted polypeptides and uses thereof | 慕尼黑工业大学 | 2019-12-31 | — | — | CN | disclosed |
| US-20190022071-A1 | METHODS OF TREATING PULMONARY DISEASES AND DISORDERS | PROTEOSTASIS THERAPEUTICS, INC. | 2019-01-24 | — | — | US | disclosed |
| WO-2018206738-A1 | LIGHT-SWITCHABLE POLYPEPTIDE AND USES THEREOF | Technische Universität München (DE) | 2018-11-15 | — | — | WO | disclosed |
| EP-0670855-A1 | NITRO OR NITROSO GROUP TERMINATED MESOGENIC EPOXY RESIN ADDUCTS | THE DOW CHEMICAL COMPANY (US) | 1995-09-13 | — | — | EP | disclosed |
| US-5412044-A | Nitro group terminated mesogenic epoxy resin adducts | THE DOW CHEMICAL COMPANY (US) | 1995-05-02 | — | — | US | disclosed |
| EP-0610014-A1 | Silicone compositions for skin care | DOW CORNING CORPORATION (US) | 1994-08-10 | — | — | EP | disclosed |
| WO-1994012555-A1 | NITRO OR NITROSO GROUP TERMINATED MESOGENIC EPOXY RESIN ADDUCTS | THE DOW CHEMICAL COMPANY (US) | 1994-06-09 | — | — | WO | disclosed |
| US-5298575-A | Consists of at least one compound having more than one vicinal epoxide group and at least one amine terminated adduct containing one or more mesogenic moities | THE DOW CHEMICAL COMPANY (US) | 1994-03-29 | — | — | US | disclosed |
| EP-0170105-B1 | BENZOIC ACID DERIVATIVES | Shudo, Koichi, Prof. Dr. (JP) | 1990-10-17 | — | — | EP | disclosed |
| US-4703110-A | Benzoic acid derivatives having a para substituent which is a substituted phenyl group connected by a linking radical; useful in neoplastic cell differentiation and diagnosis | Shudo, Koichi (JP) | 1987-10-27 | — | — | US | disclosed |
| EP-0170105-A2 | Benzoic acid derivatives | Shudo, Koichi, Prof. Dr. (JP) | 1986-02-05 | — | — | EP | disclosed |
| US-3979427-A | RHODIUM TRICHLORIDE AND COBALT IODIDE CATALYST | OLIN CORPORATION (US) | 1976-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190022071-A1 | METHODS OF TREATING PULMONARY DISEASES AND DISORDERS | SMPD1, ELANE, SMPD2 | TSHR 3266/4885TP53 4251/4885TRPA1 3362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.